FDA Peptide Committee Vote Defies Agency Crackdown
An FDA panel backed BPC-157 and KPV for compounding, handing peptide clinics a win the agency may still overrule.
Jul 24, 20266 min read0 reactions0 comments
Tag archive
An FDA panel backed BPC-157 and KPV for compounding, handing peptide clinics a win the agency may still overrule.